Double-blind study
Double-blind study is a type of study design used in clinical research to eliminate bias. It is a method of testing a drug or treatment where neither the researcher nor the patient knows who is getting the treatment or the placebo.
Overview[edit | edit source]
In a double-blind study, both the researcher and the patient are unaware of what treatment the patient is receiving. This is done to prevent bias in the results. The researcher does not know which patients are receiving the treatment or the placebo, so they cannot unconsciously influence the results. Similarly, the patients do not know whether they are receiving the treatment or the placebo, so their expectations cannot affect the outcome.
Purpose[edit | edit source]
The purpose of a double-blind study is to eliminate the possibility of bias affecting the results. Bias can occur when the expectations of the researcher or the patient influence the outcome of the study. By keeping both the researcher and the patient unaware of who is receiving the treatment or the placebo, a double-blind study aims to produce more reliable and objective results.
Process[edit | edit source]
In a double-blind study, the patients are randomly assigned to receive either the treatment or the placebo. The treatment and the placebo are identical in appearance, so neither the researcher nor the patient can tell which one they are receiving. The assignment of patients to the treatment or placebo group is done by a third party who is not involved in the study.
Advantages[edit | edit source]
The main advantage of a double-blind study is that it eliminates the possibility of bias affecting the results. This makes the results of the study more reliable and objective. Double-blind studies are considered the gold standard in clinical research.
Disadvantages[edit | edit source]
One disadvantage of a double-blind study is that it can be more expensive and time-consuming to conduct than other types of studies. Another disadvantage is that it may not be possible to conduct a double-blind study in all situations. For example, in some cases, it may be obvious to the patient whether they are receiving the treatment or the placebo.
See also[edit | edit source]
| Double-blind study Resources | |
|---|---|
|
 |
Search WikiMD
Ad.Tired of being Overweight? Try W8MD's physician weight loss program.
Semaglutide (Ozempic / Wegovy and Tirzepatide (Mounjaro / Zepbound) available.
Advertise on WikiMD
|
WikiMD's Wellness Encyclopedia |
| Let Food Be Thy Medicine Medicine Thy Food - Hippocrates |
Translate this page: - East Asian
中文,
日本,
한국어,
South Asian
हिन्दी,
தமிழ்,
తెలుగు,
Urdu,
ಕನ್ನಡ,
Southeast Asian
Indonesian,
Vietnamese,
Thai,
မြန်မာဘာသာ,
বাংলা
European
español,
Deutsch,
français,
Greek,
português do Brasil,
polski,
română,
русский,
Nederlands,
norsk,
svenska,
suomi,
Italian
Middle Eastern & African
عربى,
Turkish,
Persian,
Hebrew,
Afrikaans,
isiZulu,
Kiswahili,
Other
Bulgarian,
Hungarian,
Czech,
Swedish,
മലയാളം,
मराठी,
ਪੰਜਾਬੀ,
ગુજરાતી,
Portuguese,
Ukrainian
Medical Disclaimer: WikiMD is not a substitute for professional medical advice. The information on WikiMD is provided as an information resource only, may be incorrect, outdated or misleading, and is not to be used or relied on for any diagnostic or treatment purposes. Please consult your health care provider before making any healthcare decisions or for guidance about a specific medical condition. WikiMD expressly disclaims responsibility, and shall have no liability, for any damages, loss, injury, or liability whatsoever suffered as a result of your reliance on the information contained in this site. By visiting this site you agree to the foregoing terms and conditions, which may from time to time be changed or supplemented by WikiMD. If you do not agree to the foregoing terms and conditions, you should not enter or use this site. See full disclaimer.
Credits:Most images are courtesy of Wikimedia commons, and templates Wikipedia, licensed under CC BY SA or similar.
Contributors: Prab R. Tumpati, MD
